Susan D Reed1, Katherine A Guthrie2, Katherine M Newton3, Garnet L Anderson2, Cathryn Booth-LaForce4, Bette Caan5, Janet S Carpenter6, Lee S Cohen7, Andrea L Dunn8, Kristine E Ensrud9, Ellen W Freeman10, Julie R Hunt2, Hadine Joffe11, Joseph C Larson2, Lee A Learman12, Robin Rothenberg13, Rebecca A Seguin14, Karen J Sherman3, Barbara S Sternfeld5, Andrea Z LaCroix2. 1. Departments of Obstetrics and Gynecology and Epidemiology, University of Washington School of Medicine, Seattle, WA. Electronic address: reeds@u.washington.edu. 2. Data Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA. 3. Group Health Research Institute, Seattle, WA. 4. School of Nursing, University of Washington, Seattle, WA. 5. Division of Research, Kaiser Permanente Northern California, Oakland, CA. 6. School of Nursing, Indiana University, Indianapolis, IN. 7. Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 8. Klein Buendel, Inc, Golden, CO. 9. Department of Medicine, VA Medical Center, and Department of Medicine and Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN. 10. Departments of Obstetrics and Gynecology and Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA. 11. Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA. 12. Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN. 13. Essential Yoga Therapy, Fall City, WA. 14. Data Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Nutritional Sciences, Cornell University, Ithaca, NY.
Abstract
OBJECTIVE: The purpose of this study was to determine the efficacy of 3 nonhormonal therapies for the improvement of menopause-related quality of life in women with vasomotor symptoms. STUDY DESIGN: We conducted a 12-week 3 × 2 randomized, controlled, factorial design trial. Peri- and postmenopausal women, 40-62 years old, were assigned randomly to yoga (n = 107), exercise (n = 106), or usual activity (n = 142) and also assigned randomly to a double-blind comparison of omega-3 (n = 177) or placebo (n = 178) capsules. We performed the following interventions: (1) weekly 90-minute yoga classes with daily at-home practice, (2) individualized facility-based aerobic exercise training 3 times/week, and (3) 0.615 g omega-3 supplement, 3 times/day. The outcomes were assessed with the following scores: Menopausal Quality of Life Questionnaire (MENQOL) total and domain (vasomotor symptoms, psychosocial, physical and sexual). RESULTS: Among 355 randomly assigned women who average age was 54.7 years, 338 women (95%) completed 12-week assessments. Mean baseline vasomotor symptoms frequency was 7.6/day, and the mean baseline total MENQOL score was 3.8 (range, 1-8 from better to worse) with no between-group differences. For yoga compared to usual activity, baseline to 12-week improvements were seen for MENQOL total -0.3 (95% confidence interval, -0.6 to 0; P = .02), vasomotor symptom domain (P = .02), and sexuality domain (P = .03) scores. For women who underwent exercise and omega-3 therapy compared with control subjects, improvements in baseline to 12-week total MENQOL scores were not observed. Exercise showed benefit in the MENQOL physical domain score at 12 weeks (P = .02). CONCLUSION: All women become menopausal, and many of them seek medical advice on ways to improve quality of life; little evidence-based information exists. We found that, among healthy sedentary menopausal women, yoga appears to improve menopausal quality of life; the clinical significance of our finding is uncertain because of the modest effect.
OBJECTIVE: The purpose of this study was to determine the efficacy of 3 nonhormonal therapies for the improvement of menopause-related quality of life in women with vasomotor symptoms. STUDY DESIGN: We conducted a 12-week 3 × 2 randomized, controlled, factorial design trial. Peri- and postmenopausal women, 40-62 years old, were assigned randomly to yoga (n = 107), exercise (n = 106), or usual activity (n = 142) and also assigned randomly to a double-blind comparison of omega-3 (n = 177) or placebo (n = 178) capsules. We performed the following interventions: (1) weekly 90-minute yoga classes with daily at-home practice, (2) individualized facility-based aerobic exercise training 3 times/week, and (3) 0.615 g omega-3 supplement, 3 times/day. The outcomes were assessed with the following scores: Menopausal Quality of Life Questionnaire (MENQOL) total and domain (vasomotor symptoms, psychosocial, physical and sexual). RESULTS: Among 355 randomly assigned women who average age was 54.7 years, 338 women (95%) completed 12-week assessments. Mean baseline vasomotor symptoms frequency was 7.6/day, and the mean baseline total MENQOL score was 3.8 (range, 1-8 from better to worse) with no between-group differences. For yoga compared to usual activity, baseline to 12-week improvements were seen for MENQOL total -0.3 (95% confidence interval, -0.6 to 0; P = .02), vasomotor symptom domain (P = .02), and sexuality domain (P = .03) scores. For women who underwent exercise and omega-3 therapy compared with control subjects, improvements in baseline to 12-week total MENQOL scores were not observed. Exercise showed benefit in the MENQOL physical domain score at 12 weeks (P = .02). CONCLUSION: All women become menopausal, and many of them seek medical advice on ways to improve quality of life; little evidence-based information exists. We found that, among healthy sedentary menopausal women, yoga appears to improve menopausal quality of life; the clinical significance of our finding is uncertain because of the modest effect.
Authors: Regan L Bailey; Jaime J Gahche; Cindy V Lentino; Johanna T Dwyer; Jody S Engel; Paul R Thomas; Joseph M Betz; Christopher T Sempos; Mary Frances Picciano Journal: J Nutr Date: 2010-12-22 Impact factor: 4.798
Authors: Lee Hooper; Rachel L Thompson; Roger A Harrison; Carolyn D Summerbell; Andy R Ness; Helen J Moore; Helen V Worthington; Paul N Durrington; Julian P T Higgins; Nigel E Capps; Rudolph A Riemersma; Shah B J Ebrahim; George Davey Smith Journal: BMJ Date: 2006-03-24
Authors: Saskia F A Duijts; Marc van Beurden; Hester S A Oldenburg; Myra S Hunter; Jacobien M Kieffer; Martijn M Stuiver; Miranda A Gerritsma; Marian B E Menke-Pluymers; Peter W Plaisier; Herman Rijna; Alexander M F Lopes Cardozo; Gertjan Timmers; Suzan van der Meij; Henk van der Veen; Nina Bijker; Louise M de Widt-Levert; Maud M Geenen; Gijsbert Heuff; Eric J van Dulken; Epie Boven; Neil K Aaronson Journal: J Clin Oncol Date: 2012-10-08 Impact factor: 44.544
Authors: Rachel E Williams; Linda Kalilani; Dana Britt DiBenedetti; Xiaolei Zhou; Sheri E Fehnel; Richard V Clark Journal: Maturitas Date: 2007-10-25 Impact factor: 4.342
Authors: Rachel E Williams; Kristen B Levine; Linda Kalilani; Jacqueline Lewis; Richard V Clark Journal: Maturitas Date: 2009-01-21 Impact factor: 4.342
Authors: Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad Journal: J Affect Disord Date: 2008-08-27 Impact factor: 4.839
Authors: Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian Journal: J Natl Compr Canc Netw Date: 2017-09 Impact factor: 11.908
Authors: Janet S Carpenter; James E Tisdale; Joseph C Larson; Ying Sheng; Chen X Chen; Diane Von Ah; Richard Kovacs; Susan D Reed; Rebecca C Thurston; Katherine A Guthrie Journal: Menopause Date: 2021-11-29 Impact factor: 2.953
Authors: Susan D Reed; Andrea Z LaCroix; Garnet L Anderson; Kristine E Ensrud; Bette Caan; Janet S Carpenter; Lee Cohen; Susan J Diem; Ellen W Freeman; Hadine Joffe; Joseph C Larson; Susan M McCurry; Caroline M Mitchell; Katherine M Newton; Barbara Sternfeld; Katherine A Guthrie Journal: Menopause Date: 2020-04 Impact factor: 2.953
Authors: Tom G Bailey; N Timothy Cable; Nabil Aziz; Greg Atkinson; Daniel J Cuthbertson; David A Low; Helen Jones Journal: J Physiol Date: 2015-12-30 Impact factor: 5.182
Authors: Salene M W Jones; Katherine A Guthrie; Andrea Z LaCroix; Barbara Sternfeld; Carol A Landis; Susan D Reed; Andrea Dunn; Bette Caan; Lee S Cohen; Julie Hunt; Katherine M Newton Journal: Clin Auton Res Date: 2015-12-21 Impact factor: 5.625
Authors: Nancy Fugate Woods; Chancellor Hohensee; Janet S Carpenter; Lee Cohen; Kristine Ensrud; Ellen W Freeman; Katherine A Guthrie; Hadine Joffe; Andrea Z LaCroix; Julie L Otte Journal: Menopause Date: 2016-02 Impact factor: 3.310